Novavax (NVAX) Change in Acquisitions & Divestments (2010 - 2026)

Novavax's Change in Acquisitions & Divestments history runs 15 years deep, the most recent figure standing at $147.3 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 242.53% year-over-year to $147.3 million in Q1 2026; TTM through Mar 2026 was $458.0 million, a 5.86% decrease from a year earlier, with the FY2025 full-year figure at $353.7 million, down 20.25% from the prior year.
• Change in Acquisitions & Divestments advanced to $147.3 million in Q1 2026 per NVAX's latest filing, from $98.6 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $337.9 million in Q4 2024 and bottomed at $43.0 million in Q1 2025.
• The 3-year median for Change in Acquisitions & Divestments is $105.6 million (2024), against an average of $134.9 million.
• Across the five-year window, Change in Acquisitions & Divestments sank 70.82% in 2025 and soared 242.53% in 2026, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $337.9 million in 2024, then slumped by 70.82% to $98.6 million in 2025, then jumped by 49.37% to $147.3 million in 2026.
• Per Business Quant, the three latest NVAX Change in Acquisitions & Divestments figures stand at $147.3 million (Q1 2026), $98.6 million (Q4 2025), and $100.5 million (Q3 2025).